In this way, STING was inactivated and subsequently decreased the secretion of inflammatory cytokines, downregulating the STAT1 and NF-κB pathways in brain metastatic cells, thereby suppressing the brain metastasis of breast cancer and lung cancer [55, 56]. This evidence concerns the gene STING1 and breast carcinoma.